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ABSTRACT
Objective: To understand the experiences and support
needs of people with advanced liver disease and those of
their lay and professional carers to inform improvements
in the supportive and palliative care of this rapidly
growing but currently neglected patient group.
Design:Multiperspective, serial interviews. We
conducted up to three qualitative in-depth interviews with
each patient and lay carer over 12 months and single
interviews with case-linked healthcare professionals. Data
were analysed using grounded theory techniques.
Participants: Patients with advanced liver disease of
diverse aetiologies recruited from an inpatient hepatology
ward, and their lay carers and case-linked healthcare
professionals nominated by the patients.
Setting: Primary and secondary care in South-East
Scotland.
Results: 37 participants (15 patients, 11 lay and 11
professional carers) completed 51 individual and 13 joint
patient-carer interviews. Nine patients died during the
study. Uncertainty dominated experiences throughout the
course of the illness, across patients’ considerable
physical, psychological, social and existential needs and
affected patients, lay carers and professionals. This
related to the nature of the condition, the unpredictability
of physical deterioration and prognosis, poor
communication and information-sharing, and
complexities of care. The pervasive uncertainty also
shaped patients’ and lay carers’ strategies for coping and
impeded care planning. While patients’ acute medical
care was usually well coordinated, their ongoing care
lacked structure and focus.
Conclusions: Living, dying and caring in advanced liver
disease is dominated by pervasive, enduring and
universally shared uncertainty. In the face of high levels
of multidimensional patient distress, professionals must
acknowledge this uncertainty in constructive ways that
value its contribution to the person’s coping approach.
Pervasive uncertainty makes anticipatory care planning in
advanced liver disease challenging, but planning ‘just in
case’ is vital to ensure that patients receive timely and
appropriate supportive and palliative care alongside
effective management of this unpredictable illness.
INTRODUCTION
Chronic liver disease is the third commonest
cause of premature death in the UK and a
rapidly growing problem.1 Its leading causes are
alcohol misuse, metabolic syndromes linked to
obesity and hepatitis B and C. Chronic liver
disease affects younger people compared with
heart, lung or kidney failure. In England,
more than 1 in 10 of deaths of individuals in
their 40s are linked to liver disease.2
Comorbidities, the underlying causes of
liver disease and limited donor organ sup-
plies make liver transplantation unavailable
for a large number of patients. Many thus
stand to beneﬁt from early access to appro-
priate supportive and palliative care.3 While
access to specialist palliative care services for
people with non-malignant disease has
doubled in the past decade,4 inequalities are
still stark.5
Evidence-based guidance for the support-
ive and palliative care of people with
advanced liver disease, similar to that already
available for other non-malignant end-stage
disease, is urgently needed. People with
Strengths and limitations of this study
▪ This is the first in-depth serial interview study to
explore people’s experiences of advanced liver
disease.
▪ The multiperspective approach facilitated com-
paring and contrasting the experiences of
patients, lay carers and professionals, while
serial interviewing was key to illuminating the
complex and evolving needs and experiences of
patients and families.
▪ As patients were recruited in a single locality and
from a specialist inpatient liver unit, their care
experiences may differ from other areas and
those of patients accessing other hospitals.
▪ Given the current absence of a single agreed def-
inition of advanced or end-stage liver disease,
we developed inclusion criteria through an expert
consensus of when a palliative care approach
should be appropriate in advanced liver disease.
▪ The findings have implications for identifying
and planning optimal supportive and palliative
care in advanced liver disease, which could be
tested in a clinical trial.
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advanced liver disease face many physical and psycho-
social challenges, but in-depth research which considers
their unique care and support needs is lacking.6 We
aimed to understand the experiences, needs and prior-
ities of patients and their lay and professional carers
towards the end of life to propose effective models of
care in advanced liver disease.
METHODS
A constructivist theoretical perspective and qualitative,
multiperspective, serial in-depth interviews were chosen
to meet the aims of the study best.7 8 Constructivism
takes a relativist perspective, which considers the illness
experience an inherently subjective experience as
represented by individual, context-bound accounts.
Rather than seek to verify scientiﬁc ‘truth’, it focuses
on discovery and the creation of a deeper understand-
ing of phenomena through naturalistic methodologies
and the viewpoint of those whose experiences are the
object of investigation.9 A constructivist approach there-
fore responded well to the broad, exploratory inten-
tions of this research.
A patient and carer advisory group provided support
and guidance throughout the project.
Recruitment
Supported by clinical staff, we recruited patients present-
ing with ascites from an inpatient liver unit between
October 2011 and June 2012. Ascites is the most
common complication of advanced liver disease and an
indicator of decompensation.10 Ascites also indicates a
poor prognosis, with an expected mortality of around
50% at 2 years.11 We excluded patients who had non-
hepatic cancer or other long-term conditions as their
primary diagnosis, patients listed for liver transplantation
and those with signiﬁcant cognitive impairment.
Sampling was purposive to achieve a spread across aeti-
ologies and sociodemographics. Thirty-eight patients
were invited to participate, of whom 25 agreed. Ten
were withdrawn before their ﬁrst interview due to declin-
ing health, death or loss of contact. Nine patients died
during the study. We asked patients to nominate the lay
and professional carers most involved in their care.
Eleven lay carers took part in the study. Eleven profes-
sionals, nominated by 10 patients, were also interviewed.
Written consent was obtained before each interview,
and participants reminded that they could pause or ter-
minate the interview at any time. Ongoing verbal
consent was also ascertained at every patient contact
(face-to-face or telephone). Lay and professional carers
were asked separately for their consent.
Data generation
Demographic information was obtained from each
participant’s medical records. We calculated the
Model of End-Stage Liver Disease (MELD) score
as a measure of liver disease severity and a
deprivation category (DEPCAT) score for socio-
economic status.
We interviewed patients and lay carers up to three
times over 12 months. Interviews were conducted indi-
vidually or jointly according to participants’ wishes.
Patients were telephoned bi-monthly by the researcher
so that follow-up interviews could be arranged ﬂexibly to
capture key changes in the person’s condition or cir-
cumstances while being sensitive to the needs of the par-
ticipant at that time. Interviews were conducted by an
experienced qualitative researcher (BK) and lasted 30–
150 min. Most patient and carer interviews took place in
the patient’s or carer’s home, a small number were con-
ducted in a quiet room on the hospital ward. One-off
interviews with case-linked professionals were conducted
to contextualise the patient and carer data. Professional
interviews were conducted face-to-face or by telephone
as preferred to further encourage participation. All
interviews were audio recorded and detailed ﬁeld notes
kept to contextualise the interview data.
Patients and lay carers were asked about their experi-
ences of liver disease, their current physical, psycho-
social, existential and information needs and their
thoughts about the future. Follow-up interviews explored
evolving needs and the adequacy of services and support
provided. Bereavement interviews with lay carers
explored the patient’s terminal phase of illness and
death, and the support and care offered then. Interviews
with professionals sought their views, experiences and
perceived challenges in providing effective care.
Interview guides were used ﬂexibly to allow participants
to express their greatest concerns.
Data analysis
All interviews were transcribed and analysed by BK
aided by qualitative data management software QSR
NVivo V.9. Data analysis drew on constructivist
grounded theory and its techniques of coding, constant
comparison and memo-writing.12 It involved an iterative
process of separating, sorting and synthesising the data,
leading from generic substantive coding to increasingly
abstract and theoretical coding. Codes and categories
were compared to identify differences and similarities,
and reﬁne and modify codes. Contextual information
from the ﬁeld notes as well as regular discussions with
the multidisciplinary research team and the study’s lay
advisory group added depth and breadth to data
interpretation.
The data were analysed: (1) by participant group
(patients, lay carers or professionals), (2) by ‘integrated
case’ (case-linked patient/carer/professional triads) and
(3) longitudinally to illuminate participants’ evolving
needs. This analysis was informed by a menu of ques-
tions designed to stimulate the exploration of change.13
Comparisons across these data sets allowed consideration
of commonalities and differences between groups, cases
and over time.
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Quality assurance
A detailed audit trail was recorded to facilitate quality
assessment of the study conduct.14 Procedural decisions
taken during the recruitment and data generation
phases of the research were recorded in extensive ﬁeld
notes. An analytical decision trail was documented in
NVivo through a detailed data analysis journal, copies of
the coding structure at different time points and time-
stamped memos showing evolving analytical ideas about
cases, codes and categories. The study conduct met
COREQ criteria for reporting qualitative studies.15
RESULTS
We recruited 15 patients, 11 lay carers and 11 case-
linked professionals. There were seven male and eight
female patients with an average age of 58.8 (range 35–
84). Their primary disease aetiologies were: alcohol-
related liver disease (ALD), non-alcoholic fatty liver
disease (NAFLD), hepatitis C (HCV), primary hepatocel-
lular carcinoma, autoimmune hepatitis and cryptogenic
liver disease. The mean MELD score at recruitment was
16.3 (range 9–26). Nine patients lived with their lay
carers, six lived alone. The case-linked professionals
comprised eight general practitioners and one consult-
ant hepatologist, hospital-based alcohol liaison nurse
and community palliative care nurse each. Fifty-one indi-
vidual interviews were conducted, 13 of these jointly
with patient and lay carer. Three carers agreed to
bereavement interviews. Table 1 gives an overview of the
participants and interviews.
Overview of findings
The extensive physical and psychological burden in
advanced liver disease described previously was evident.6
The key factor which emerged as unifying the experi-
ences of all participants however was pervasive uncer-
tainty. Uncertainty is described as a person’s inability to
extract meaning from illness-related events.16 This
occurs “when details of situations are ambiguous,
complex, unpredictable or probabilistic; when informa-
tion is unavailable or inconsistent; and when people feel
insecure in their own state of knowledge or the state of
knowledge in general” (ref. 17, p. 478). We describe
how uncertainty dominated all participants’ accounts
and deﬁned their experiences.
Ambiguous onset and confused understanding of the
disease
Patients’ experiences of the onset of their illness were
characterised by the insidious nature of their early symp-
toms and uncertainty about whether to consult their
general practitioner (GP), often resulting in the diagno-
sis of liver disease at an advanced stage.
I didn’t feel particularly well, but I couldn’t tell you why I
didn’t feel well. I just had put it down to the fact I was a
bit stressed out. (Patient 11, female, 41, ﬁrst interview)
Receiving a diagnosis was a similarly ambiguous event,
magniﬁed by difﬁculty understanding the professional
language. Use of the word ‘cirrhosis’ was particularly
confusing for those with aetiologies other than alcohol
Table 1 Overview of patient participants and interviews conducted
Patient Aetiology DEPCAT
MELD at
recruitment
Months
in study
Admissions
during study
involvement
Interviews per time point
(P=patient; C=carer;
P&C=joint)
Status
at end
of study
Male, 68 ALD 4 14 12 0 P&C1, P&C2, P&C3 Alive
Female, 38 ALD, HCV 5 20 12 3 P1, P2, P3, C1, C2, C3; GP Alive
Female, 66 AIH 4 20 5 5 P1, P2 Dead
Female, 60 ALD 5 17 7 6 P1, P2, C1, Bereavement;
Consultant
Dead
Female, 84 NAFLD 4 9 11 13 P1, P2, P3 Dead
Male, 74 HCC
(NAFLD)
7 17 1 0 P1, Bereavement; GP Dead
Male, 77 ALD
(NAFLD)
6 9 9 21 P1, P&C2, P&C3; GP; Palliative
Care Nurse
Dead
Male, 75 NAFLD 3 21 6 9 P1; GP Dead
Male, 35 ALD 4 24 12 5 P1, P2, P3, C1, C2; Alcohol
Liaison Nurse
Alive
Male, 58 ALD 5 13 6 7 P1 Dead
Female, 41 Cryptogenic 3 10 8 5 P&C1, P2, C2, P&C3; GP Alive
Female, 56 ALD, HCV 4 13 6 0 P1 Alive
Female, 45 ALD 3 16 7 2 P1, P2; GP Dead
Female, 68 NAFLD 3 15 5 9 P&C1, Bereavement; GP Dead
Female, 37 ALD 7 26 9 2 P&C1, P&C2, P&C3; GP Alive
(DEPCAT (Deprivation Category index): 1=least deprived; 7=most deprived).
AIH, autoimmune hepatitis; ALD, alcohol-related liver disease; GP, general practitioner; HCC, hepato-cellular carcinoma; HCV, hepatitis C
virus; MELD, Model of End-Stage Liver Disease; NAFLD, non-alcoholic fatty liver disease.
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excess, as people tended to associate the term with this
cause.
Patient: They just told me that I had liver…they called it
another name, it sort of fooled me for a wee while. (…)
Interviewer: Cirrhosis? (…)
P: That was it. And it wasn’t until I seen it printed in a
letter they sent me, when I got the letter that’s when I
realised it was [primary liver] cancer.
(Patient 6, male, 74, ﬁrst interview)
Patients’ physical experiences described a gradual
decline punctuated by unpredictable but relatively short-
lived episodes of decompensation (eg, ascites) and more
dramatic acute events (eg, gastrointestinal bleeding),
which both required inpatient treatment. Patients felt
satisﬁed with the acute medical care they received on
such occasions. The problems that most often disrupted
daily life were fatigue and ascites. Many patients also
reported intermittent problems with mobility and
balance. A lack of understanding of the cause of these
problems and their unpredictable occurrence fostered
more uncertainty. Several people recounted incidents of
falling, making them lose conﬁdence in their abilities
and restrict their activities to avoid further falls.
Extensive, complex and ever-changing medication regi-
mens were a further source of uncertainty for patients
and caregivers alike.
Regardless of aetiology, most patients had had little
knowledge of liver disease prior to their diagnosis,
reﬂecting a general lack of public discourse about this
condition. This was reinforced by a perceived lack of
education as part of their ongoing medical care. As a
result, patients were unsure which physical symptoms to
ascribe to their liver disease.
This lack of energy thing, I mean, is that quite normal for
somebody who’s got liver disease (…) or am I just milking
it a bit? Should I be ok or what? I don’t know what all this
is about. (Patient 11, female, 41, ﬁrst interview)
Clarity about their situation was further hampered by
conﬂicting information received from the different pro-
fessionals involved in their care. At the same time,
patients’ poor understanding of their condition left
them unsure what to ask professionals. Participants were
particularly poorly informed about what to expect from
their illness and how it might progress in the future,
leaving them unsure how to cope and plan.
Somebody should be able to sort of say, “Well this will
happen sometime or that will happen sometime,” and you
know, warn you what it’s going to do and what you’ve got
to do when it happens. (Patient 8, male, 75, ﬁrst interview)
However, not everyone felt that more speciﬁc informa-
tion was required. Preparing patients and their families
for the realities of living with an illness as unpredictable
and uncertain as advanced liver disease was in itself con-
sidered empowering by some.
People get frustrated about not knowing what’s going on
(…), but if you say right at the onset this is what’s going to
happen, it’s going to be a big rollercoaster, it is going to
be full of ups and downs, there’s going to be lots of times
of nothing happening, people will come and change opi-
nions by the second and that’s what is literally going to
happen, be ready for it. (…) That in itself for me is under-
standing what’s going on. (Lay carer 11, second interview)
Uncertainty as a feature of everyday life
Employment was particularly important for this younger
group of people. Inability to work caused ﬁnancial pres-
sures, with some patients becoming increasingly depend-
ent on their families. Their caregivers felt under similar
pressure. Those with alcohol-related disease were pre-
occupied with the challenges of overcoming their
dependency, which added to their psychological burden.
Participants were acutely aware of the stigmatising repu-
tation of liver disease and its popular association with
alcohol misuse. Participants adopted strategies for avoid-
ing potentially stigmatising situations, such as eschewing
social contact or discussion of their condition.
Increasing physical complications distressed partici-
pants, realising that recovery was unlikely and fearing
future deterioration. Despite expressions of acceptance
of their situation, low mood was pervasive.
Sometimes I lie in the room and cry and just think about
things, you know, things that you could remember that
you could do and now you can’t. (Patient 4, 60, ﬁrst
interview)
Patients and their lay carers tended to deal with the
uncertainty of the situation by simply ‘getting on with it’
and hoping for the best. This indicated a deliberate cog-
nitive and emotional distancing to enable better coping.
A key strategy for maintaining a positive mind-set was to
put faith in healthcare professionals’ abilities and
commitment.
A lack of awareness of what types of support were avail-
able to them meant that many patients and lay carers
struggled to articulate what support they would value
most. Professionals similarly showed a lack of awareness
of support services.
I don’t know of many support services. That’s a bit of a
worry actually, considering that I’m the last point of
contact for people. (…) Are there any speciﬁc services
for folks with liver conditions? I don’t know any of them
if there are any. (Community palliative care nurse)
Inadequate doctor–patient communication and
discontinuity of care
Patients considered the time available during appoint-
ments too limited for effective information exchange.
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They also criticised hospital staff for regularly approach-
ing them and advising on their care without making
their role and authority to do so clear enough. This left
patients and families unsure about where these instruc-
tions were coming from. Several participants also felt
that explanations were often too medicalised.
What they’re saying is, “Right, your potassium level’s at
such and such, your sodium level’s at such and such,”
what else, “your blood count was this, your blood pres-
sure was that.” (…) and they don’t actually tell me what it
means. It is good? Is it bad? Is it happy medium? I don’t
know. (Patient 15, female, 37, second interview)
Relational and organisational continuity of care were
consistently inadequate in primary and secondary care
settings. This added another dimension of uncertainty.
Being able to see the same GP who knew about their
condition varied across participants and many lacked
continuity of care with their designated consultant.
Many participants also remarked on the frequent turn-
over of hospital nursing and clinical staff.
Follow-up care was delivered through outpatient
appointments and the monitoring of bloods commonly
undertaken in primary care. However, attendance at
follow-up appointments was often impeded by illness-
related factors, lack of support and repeated hospitalisa-
tion. Some participants also questioned the usefulness
of these appointments. Gaps between hospital appoint-
ments were also considered unhelpfully long.
It’s just basic. They just ask how I’ve been feeling, have I
had a drink, are you eating well? And then they’ll put
you on the bed and have a wee prod about and then take
your blood and that’s it. (Patient 9, male, 35, second
interview)
What tended to happen was [patient] would be in hos-
pital very unwell, have ﬂuid, his ascites drained off and
then he’d come out and I’d say, “So when’s your next
follow-up appointment?” and he would say, “Oh, I’m
seeing [consultant] in three or four months.” And to me
that didn’t seem appropriate. (…) It seemed far more
appropriate that he was seen on a more regular basis
(GP8).
The experiences of care as described above were not
found to change over time.
Uncertainty as a barrier to talking about and planning for
deteriorating health and dying
Giving and receiving a prognosis was beset with uncer-
tainty. GPs felt they lacked expertise and conﬁdence
and thought conversations about progression and prog-
nosis should be conducted by specialists. Patients also
differed in the extent to which they wished to know
their prognosis. As a result, prognosis was rarely
discussed.
Most professionals interviewed had not engaged in
advance care planning with patients with liver disease,
citing difﬁculty in pinpointing the appropriate time to
start this. Additionally, specialists’ tendency to continue
interventions until the ﬁnal stages of the illness left GPs
unsure about the status of their patient’s condition and
thus when to consider them for palliative care.
Interviewer: Was there any particular point or event from
where you felt that she needed a palliative care approach
or maybe to put her on the [palliative care] register?
GP14: No, not particularly, you know? I mean they kept
transfusing her, so they didn’t say, “Stop transfusing her.”
Specialists however tended to address this issue with
patients only when their terminal phase was evident, by
which point conversations could be difﬁcult to conduct.
Interviewer: What would normally be your trigger point
for initiating those sort of conversations?
Consultant: Well, I think when you are clear people are
dying, you know? (…) The difﬁculty with these patients
is that often by the time that you know they are dying
they’re often too confused or unwell or sleepy to actually
have that conversation so, you know, it can be difﬁcult.
GPs’ reluctance to contradict specialist colleagues and
uncertainty regarding their own place in a patient’s care
constituted further barriers.
Maybe I should have written a letter to the consultant to
say, “Look, we’re treating this as palliative care, is it pos-
sible to step back on the thing?” But somehow you don’t
feel that it’s your place to say that, because they’re under
the care of a liver specialist who obviously knows what
they’re doing. (GP7)
Finally, there was consensus among all the profes-
sionals that palliative care for people with liver disease
deserved more attention. Several GPs mentioned the
usefulness of specialist nurses who support people with
other conditions such as heart failure, and were unsure
whether these existed for those with liver disease.
DISCUSSION
Summary
Pervasive and enduring uncertainty throughout the
course of the condition deﬁned and uniﬁed the experi-
ences of patients, lay carers and professionals. This
related to the vague and unpredictable nature of the
disease, limited understanding of the condition and its
likely progression, lack of effective communication and
discontinuity of care. Increasingly frequent, debilitating
complications brought acute episodes of physical and
psychosocial distress in the context of a gradual overall
decline in health. While patients’ acute medical care
appeared to be largely well-coordinated, their ongoing
care in the community lacked structure and focus.
Forward planning was largely absent. Care was symptom-
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focused, episodic and reactive, in primary and secondary
care settings, and was consequently poorly aligned with
the long-term, multidimensional needs of this patient
group. GPs appeared disempowered due to a lack of
experience, conﬁdence and being uncertain about their
role in these patients’ care.
Comparison with existing literature
Patients experienced an erratic trajectory of physical
and psychosocial distress similar to that reported in
heart failure and chronic obstructive pulmonary
disease.18 19 This in-depth, serial interview study of
people with advanced liver disease is the ﬁrst to
describe the impact of insufﬁciently coordinated care
that was largely focused on disease management in hos-
pital. Patients with advanced heart and respiratory dis-
eases often beneﬁt from the support of specialist nurses
and allied health professionals,20 21 but such services
are not available for those with liver disease in general.
In addition to debilitating physical complications and
pervasive medical uncertainty, which together created a
substantial and enduring psychological burden, patients
and lay carers also faced several personal and social
sources of uncertainty. This mirrors previous research in
this patient group.22 23 Participants recounted instances
of enacted and perceived stigma in their clinical care
and everyday life, which paralleled the patient experi-
ence in lung cancer and previous accounts of liver
disease.24–26
Implications for managing inherent uncertainty in
advanced illness
Uncertainty is characterised by ambiguity, vagueness,
unpredictability and incomplete information.27 Osler
declared that, “Medicine is a science of uncertainty
and an art of probability.”28 Skill in dealing with uncer-
tainty is therefore an art professionals must learn and
share with patients and lay carers. Being explicit about
the uncertain nature of the condition may in itself
reduce patients’ anxieties.29 After all, Hippocrates
stated that the ability to forecast the future course of
the illness, including the uncertainties, is what is most
appreciated by patients.30 Being aware of inevitable
uncertainty is important and empowering and likely to
help people live as well as possible with deteriorating
health.
Uncertainty can challenge a person’s ability to cope
with and adapt to chronic illness.31 In this study, possibly
due to a lack of scope for reducing uncertainties,
patients principally sought to manage uncertainty based
on their assessment of whether having certainty about
their situation would empower or undermine them.32
Living with uncertainty can also a preferred state for
some patients with chronic obstructive pulmonary
disease.19 This conﬁrms that reducing uncertainty is not
necessarily a person’s desired goal.33
Psychosocial support is key to the successful manage-
ment of uncertainty and thus better coping, but was
notably absent. Uncertainty proved a key barrier to
advance care planning and consequently hindered the
labelling of patients as ‘palliative’. This mirrors, but we
found was more pervasive, than in other organ failure
conditions and cancer.34–36 Continued hospital treat-
ments, even where those were palliative in nature such
as blood transfusions and paracentesis, contributed to
GPs’ uncertainty as to the appropriateness and timing of
mentioning a palliative care approach. The erratic and
unpredictable trajectory of advanced liver disease means
that the focus should be shifted from asking, “Is it time
for a palliative care approach yet?” to considering the pro-
blems faced by patients and families as a whole as their
illness progresses, what their goals and needs are and
who can help with those most effectively.37 Moreover,
participants trusted healthcare professionals to have
their best interests at heart. Trust and conﬁdence in
one’s healthcare provider is not only key to reducing
uncertainty in the ill person,16 but can offer a sound
basis for introducing anticipatory care conversations.
Implications for practice and research
Patients and their families need better education and
information about the typical features of advanced liver
disease. Promoting public awareness may lead to earlier
diagnosis and less prejudice. Ongoing opportunities to
seek information and ask questions are needed through-
out the illness. Professionals should be open with
patients about the uncertain prognosis and progression.
This may also facilitate anticipatory care planning by
encouraging the idea of ‘hoping for the best, but pre-
paring for the worst’. Ascertaining patients’ individual
perceptions of uncertainty enables information-sharing
and interventions that complement that person’s
approach and thus support coping.
Despite patients voicing concern about their GPs’
lack of expertise in liver disease, there may be little
value in developing their specialist knowledge.38
Participants considered their medical care to be largely
satisfactory, but lacked coordinated care and focused
psychosocial support. Primary care teams have expert-
ise in the holistic care and management of people with
advanced long-term conditions, but this works best if
patients are identiﬁed and primary and secondary care
services collaborate and communicate effectively so
that important conversations and care plans are shared.
Continuity in care relationships was poor in primary
and secondary care settings, and inpatient and out-
patient care. Access to a single co-ordinating care profes-
sional can help avoid unplanned hospitalisation and is
key to good end-of-life care.39 40 The utility of a commu-
nity liaison liver nurse specialist should be evaluated.
This nurse might take the lead in managing and
co-ordinating patients’ ongoing care in the community,
which would address several of the identiﬁed shortcom-
ings, and liaise with other services, such as specialist pal-
liative care, when needed. Box 1 provides a summary of
proposed service improvements.
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Box 1 Practical suggestions for clinicians caring for
patients with advanced liver disease and their lay carers
▸ Explain how the patient’s symptoms may relate to the illness
(eg, lack of energy) and explain about other common pro-
blems they may encounter.
▸ Acknowledge the inherent uncertainties in the condition, and
involve patient and carer in making a plan in advance to deal
with these uncertainties.
▸ Be mindful of patient-friendly communication: introduce your-
self, avoid ambiguous language or medical jargon, provide
opportunities to ask questions and clarify issues.
▸ Build on the patient’s current understanding and individual
approach to coping with uncertainty.
▸ Discuss wider life circumstances and assess for and address
low mood.
▸ Build on patient and carer trust in healthcare professionals to
encourage anticipatory care conversations; revisit these frequently.
▸ Identify and promote support services/resources available to
liver patients and their carers.
▸ Strengthen communication with palliative care services and
other allied professions to maximise their involvement.
▸ Strengthen communication with members of the patient’s
healthcare team across settings to ensure complementary and
timely follow-up.
▸ Promote public understanding of liver disease, raising aware-
ness about its insidious nature and dispelling myths to reduce
its stigmatising reputation.
Strengths and weaknesses of the study
This is the ﬁrst in-depth serial interview study to explore
people’s experiences of advanced liver disease outside of
transplantation. A key strength of this study was its meth-
odology. The inclusion of a spectrum of ages, genders
and disease aetiologies served to highlight the relative uni-
formity of the patient experience in advanced liver
disease. Similarly, the multiperspective approach facilitated
comparing and contrasting the experiences of patients,
lay carers and professionals. Serial interviewing was key to
illuminating the complex and evolving needs and experi-
ences of these patients and families. Our bi-monthly tele-
phone calls enabled us to ensure the interviews captured
the dynamic events and experiences.
Patients were recruited in a single locality in the UK
and from a specialist inpatient liver unit. Their care
experiences may therefore differ from other areas and
those of patients accessing other hospitals. In the absence
of a single agreed deﬁnition of advanced or end-stage
liver disease, the inclusion criteria constituted an empir-
ical measure that may not be representative of this patient
population at large. Asking patient participants to nomin-
ate the professionals to be interviewed meant an absence
of control over the type of professions that would be
represented, resulting in a sample dominated by GPs.
Ethnic minorities were missing from the study sample.
CONCLUSION
Living, dying and caring with advanced liver disease is
dominated by pervasive, enduring and universally
shared uncertainty. Uncertainty not only deﬁnes every-
one’s experiences, but proves a key mediating factor in
their actions. Acknowledging the inevitable uncertainties
related to a condition may facilitate the introduction of
care planning conversations by encouraging the idea of
‘hoping for the best, but preparing just in case’.
Professionals must acknowledge uncertainty in construct-
ive ways that support effective coping, while also ensur-
ing that patients and families receive timely and
appropriate supportive and palliative care alongside
effective management of this unpredictable and increas-
ingly common life-limiting illness.
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